Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: May 18, 2011

Drug Name Review Type Class Manufacturer
Dulera New Drug Appeal Beta Adrenergic/Glucocorticoid Merck
Seroquel PDL Appeal Atypical Antipsychotic Astra Zeneca
Seroquel XR PDL Appeal Atypical Antipsychotic Astra Zeneca